Fagus Grandifolia Pollen Injection, Solution
NDC Package 0268-6607-06
Package Information
Fagus Grandifolia Pollen (beech) injection is these products are for diagnostic use only. This formulation utilizes a injection, solution delivery system. Marketed by Alk-abello, Inc., this product is identified by NDC 0268-6607 and is authorized under FDA application BLA103753.
Identification & Billing
- RxCUI: 1013964 - bald cypress pollen extract 50 MG/ML Injectable Solution
- RxCUI: 1013964 - bald cypress pollen extract 0.05 GM/ML Injectable Solution
- RxCUI: 1013964 - Taxodium distichum pollen extract 0.05 GM/ML Injectable Solution
- RxCUI: 1013964 - Taxodium distichum pollen extract 50 MG/ML Injectable Solution
- RxCUI: 1014194 - cedar elm pollen extract 50 MG/ML Injectable Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0268 - Alk-abello, Inc.
- 0268-6607 - Fagus Grandifolia Pollen
- 0268-6607-06 - 5 mL in 1 VIAL, MULTI-DOSE
- 0268-6607 - Fagus Grandifolia Pollen
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0268-6607-06 identifies a specific commercial package of 5 ml in 1 vial, multi-dose of Fagus Grandifolia Pollen, a non-standardized allergenic label labeled by Alk-abello, Inc.. This injection, solution is formulated for percutaneous use and contains fagus grandifolia pollen as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alk-abello, Inc. on January 01, 1965. The current certification is valid through December 31, 2026.
How is this Alk-abello, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00268660706. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.